The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease (Q44030656)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease
scientific article

    Statements

    The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease (English)
    Kenneth R Chapman
    Peter Arvidsson
    A G Chuchalin
    D P Dhillon
    Peter Faurschou
    Roger S Goldstein
    A F Kuipers
    International study group
    178-185

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit